To the Editor: The Australian Pharmaceutical Benefits Scheme records 35 657 prescriptions (for either one or two devices) for EpiPen autoinjectors (CSL Limited, Melbourne, VIC), the self-injectable form of adrenaline, in 2006. This is a 650% increase on the 4758 prescriptions for EpiPens in 1998. The increase is much greater than the increase in the rate of food allergy.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1 Department of Allergy, Immunology and Infectious Diseases, The Children’s Hospital at Westmead, Sydney, NSW.
- 2 Discipline of Paediatrics and Child Health, University of Sydney, Sydney, NSW.
Correspondence: andrewk5@chw.edu.au
- 1. Kemp A. EpiPen epidemic: suggestions for rational prescribing in childhood food allergy. J Paediatr Child Health 2003; 39: 372-375.
- 2. Gold MS, Sainsbury R. First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen). J Allergy Clin Immunol 2000; 106: 171-176.
- 3. Mehr S, Robinson M, Tang M. Doctor — how do I use my EpiPen? Pediatr Allergy Immunol 2007; 18: 448-452.
- 4. Arkwright PD, Farragher AJ. Factors determining the ability of parents to effectively administer intramuscular adrenaline to food allergic children. Pediatr Allergy Immunol 2006; 17: 227-229.
- 5. Hu W, Grbich C, Kemp A. Parental food allergy information needs: a qualitative study. Arch Dis Child 2007; 92: 771-775.
Online responses are no longer available. Please refer to our instructions for authors page for more information.